The Barbados reference laboratory now offers a quantitative detection analysis of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Spike glycoprotein antibodies. This test is useful for the identification of individuals who have an adaptive immune response to the SARS-COV-2 Spike glycoprotein by way of exposure or through vaccination.